In-House Lyophilization vs Outsourcing: How to Decide

When you compare in-house lyophilization vs. outsourcing, the freeze dryer is the smallest cost on the list. A capable pilot-scale unit costs less than the quality system, validation work, and specialist staff needed to turn it into a manufacturing process your customers and regulators will accept.

For a first lyophilized product, outsourcing is usually the better decision. Bring the process in-house when three things are true at once: volumes are steady and high enough to keep equipment busy, lyophilization is part of what differentiates your product, and you already have someone who can develop and defend a drying cycle. If any one of those is missing, you are buying equipment to learn a discipline on your own launch timeline.

What lyophilization equipment really costs

Indicative market prices, with the quality system costs that come with them:

ItemIndicative costNotesBenchtop freeze dryer$5,000 to $25,000Feasibility and small R&D batches (Excedr)Mid-scale laboratory lyophilizer$25,000 to $100,000More shelf area, stoppering, better controlLarge-scale industrial system$100,000 to $500,000+Before installation, utilities and serviceISO 13485 certification, small company, first yearRoughly $56,000 to $138,000Consultants, staff time, eQMS, registrar audits (MedDeviceGuide)ISO 13485 annual surveillance$5,000 to $10,000 per yearRecurring, before recertification

Lower estimates for ISO 13485 exist. One guide puts small-company totals at $15,000 to $40,000 (Elexes). The spread mostly reflects how much quality infrastructure you already have; if you already hold ISO 13485, adding a process is far cheaper.

Beads add equipment that a cake process does not need: precise droplet dispensing into liquid nitrogen, cryogen handling and safety, bead weight QC, and a low-humidity room or glovebox for filling and pouching. None of it is exotic. All of it has to be qualified.

The cost that rarely appears in the spreadsheet is time. From a standing start, ISO 13485 certification typically takes 10 to 18 months (MedDeviceGuide). Equipment lead time, installation, and IQ/OQ/PQ run alongside it, and formulation and cycle development cannot finish until the production equipment is qualified.

Cost per unit: where buying equipment starts to pay off

The fairest way to compare lyophilization equipment with contract manufacturing is cost per unit, because that is how a contract manufacturer quotes. The in-house figure is mostly fixed cost, so it depends almost entirely on volume.

Here is a deliberately conservative illustration using the low end of the figures above: a $100,000 production-capable dryer written off over five years ($20,000 per year), plus about $56,000 of first-year quality system cost, falling to about $5,000 per year in surveillance audits afterwards. That gives roughly $76,000 of fixed cost in year one and $25,000 in each later year.

Annual volume (beads or tests)Fixed cost per unit, year one Fixed cost per unit, later years10,000$7.60$2.50100,000$0.76$0.251,000,000$0.08$0.03

These numbers leave out staff, utilities, liquid nitrogen, consumables, validation runs, and failed batches, so the real in-house figure is higher at every volume. Even so, the pattern is clear. At tens of thousands of units a year, fixed costs alone add dollars to every unit before anyone is paid to run the dryer. At a million units a year, they almost disappear.

To run the comparison for your own product, build the full annual in-house cost (equipment depreciation, quality system, staff, utilities, materials, rejected batches), divide by your realistic volume for the next three to five years, and set that against contract quotes at the same volume. Then add the value of launching a year or more earlier, which usually decides the question for first products.

Why a benchtop cycle does not become a production process

Most in-house programs start with a benchtop dryer, a promising feasibility result, and an assumption that the same cycle will run on bigger equipment. It will not.

Small freeze dryers deliver a much larger share of their heat by radiation from walls and doors. In one characterization of laboratory, pilot, and production dryers, a front vial in the laboratory unit received 1.8 times more heat than a front vial in the manufacturing dryer at the same shelf temperature and chamber pressure (Rambhatla & Pikal, AAPS PharmSciTech, 2006). Shelf design, condenser capacity, and refrigeration limits differ too, and the scale-up literature treats transfer between dryers as a development task in its own right (AAPS PharmSciTech, 2023).

This is where outsourcing earns most of its value. A specialist manufacturer has already characterized its own equipment, so your formulation is developed on the dryer that will produce it. In-house teams often develop twice: once on the benchtop unit, then again on the production unit they bought later.

The regulatory load moves with the manufacturing

On February 2, 2026, the FDA's Quality Management System Regulation took effect, amending 21 CFR Part 820 to incorporate ISO 13485:2016 by reference (FDA). For US and EU markets, the practical result is one quality standard to meet. If you lyophilize in-house, that process sits inside your quality system: validated, documented, and inspectable.

Outsourcing does not remove your responsibility. Under the EU IVDR, a company that places a device on the market under its own name takes on the manufacturer's obligations (Regulation (EU) 2017/746, Article 16). ISO 13485 purchasing controls require you to qualify and monitor your supplier. What changes is the type of work: supplier qualification, quality agreements, and documentation review, instead of running and validating the process yourself.

In-house lyophilization vs outsourcing: decision matrix

FactorFavors in-houseFavors outsourcingAnnual volumeHigh and predictableLow, early or uncertainProduct portfolioMany lyophilized products sharing one platformOne or two productsLyophilization expertise on staffExperienced formulation and cycle scientistNone, or one person learningExisting QMSISO 13485 already in placeNo certified QMSTime to marketLaunch 18+ months awayLaunch within a yearDifferentiationProprietary drying process is part of the productValue lies in the assay, brand or channelFormatStandard vials on existing linesBeads, cartridges or custom packagingCapital positionCapital available and plannedCapital better spent on sales, clinical data or regulatory

If most of your answers fall in the right-hand column, the case for building is weak regardless of what the equipment quote says.

What outsourcing costs you, and how to limit it

Outsourcing has real downsides, and ignoring them leads to bad supply agreements.

Dependency. A single supplier is a single point of failure. Negotiate tech transfer rights or a documented second-source plan into the agreement from the start, not after a supply problem.

Knowledge stays outside. Your team learns less about why the formulation works. Ask for development reports, stability data, and critical process parameters as deliverables.

Unit cost at scale. At high, stable volumes, a supplier margin eventually exceeds what an efficient in-house line would cost. That crossover point is real, but it usually arrives years after launch, if at all.

IP and confidentiality. Be explicit about who owns the formulation, the process, and any improvements. A good supplier will expect this conversation.

One factor works in favor of outsourcing for lyophilized products specifically. Ambient-stable reagents are cheap to hold as inventory. Holding several months of safety stock at room temperature does not need freezer space or cold-chain shipping, which makes supplier risk much easier to manage than it is for liquid reagents.

The hybrid path most teams end up on

In practice, the choice is rarely all or nothing. A common route is to keep a benchtop freeze dryer for early feasibility work, outsource development and commercial manufacturing, and revisit the build decision once volumes justify it.

If you want a finished product under your own brand instead of a manufacturing project, white-label supply removes most of the development step. You add ready-made EVIK™ DxSpheres to your catalog as they are, or customized, with the supplier carrying process development and production.

Need a fully custom formulation developed from scratch? Evik Diagnostics offers lyobead contract development and manufacturing, including integration into vials, tubes, plates, and microfluidic cartridges. For an overview of the bead format itself, see our page on lyophilized reagent beads.

Frequently Asked Questions

Is it cheaper to buy a freeze dryer or use a contract manufacturer?

At low and moderate volumes, contract manufacturing is usually cheaper once quality system, staff and validation costs are included. Buying equipment starts to pay off only when volumes are high and stable enough to spread those fixed costs thinly across many units.

How much does lyophilization equipment cost?

About $5,000 for a benchtop unit, $25,000 to $100,000 for a mid-scale laboratory system, and $100,000 to $500,000 or more for industrial equipment. A small company building an ISO 13485 quality system from scratch should budget roughly $56,000 to $138,000 in the first year on top of that.

How long does it take to bring lyophilisation in-house?

Plan on more than a year from a standing start. ISO 13485 certification alone typically takes 10 to 18 months, and cycle development cannot be finalized until production equipment is installed and qualified.

Does outsourcing reduce my regulatory obligations?

It changes them without removing them. The company whose name is on the product carries manufacturer obligations and must qualify and monitor its supplier under ISO 13485.

Add lyobeads to your product line As-is or customized, under your own brand. Get specifications, customization options, MOQs and timelines. Partner Pack